P2Y12 Inhbitors in the ED for NonSTEMI. Criticisms of the ACCOAST-ed trial of Upstream vs. Delayed Prasugrel
Rick Body had a nice piece in St. Emlyn’s about the ACCOAST-ed trial, a study recently published in the NEJM on the use of Prasugrel in…